H. References, Back to the index of the Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA

• Statutory instrument 2004/1031: The Medicines for Human Use (Clinical Trials) Regulations 2004 (https://www.legislation.gov.uk/uksi/2004/1031/pdfs/uksi_20041031_en.pdf).

• Statutory Instrument 2006/1928: The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (https://www.legislation.gov.uk/uksi/2006/1928/pdfs/uksi_20061928_en.pdf).

• See also MHRA GCP Guide 2012 (https://www.gov.uk/guidance/good-clinical-practice-for-clinical-trials)

Back to the index of the Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA, Medicines & Healthcare products Regulatory Agency

 

Clinical Research News

Huntington’s Disease: Scientists to Re-Test a Drug Aimed at Preserving Memory and Movement
Blisters, Fever, and Lost Appetite: New Vaccine Against Hand, Foot, and Mouth Disease to Be Tested on 6,000 Children
Helping Your Gut on GLP-1: Can a Daily Fiber Supplement Boost Metabolism During Weight Loss?
Heart Attack and Stroke Risks Can Develop for Years: Sweden to Test Home Screening Kits
Preventive Cancer Vaccine to Be Tested in People with Lynch Syndrome
Type 1 Diabetes Can Develop Silently: New Screening Method to Be Tested During Routine Pediatric Visits
Pancreatic Cancer Is Often Caught Too Late: Japan to Test a New Blood Screening Method

Prossimi studi clinici

Clinical Research Jobs

More jobs

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

Sottoscrivi